Borosil Scientific debuts on stock exchange
This strategic decision will unlock significant value for our scientific and industrial products business
This strategic decision will unlock significant value for our scientific and industrial products business
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Pivotal OASIS 1 and 2 Phase III studies of investigational compound elinzanetant achieved a statistically significant reduction in frequency and severity of vasomotor symptoms
Recommendation based on CAPItello-291 results which showed the Truqap combination reduced the risk of disease progression or death by 50%
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Fluid bed processes: drying, granulating, and coating in just one product container
Subscribe To Our Newsletter & Stay Updated